Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silver fluoride versus atraumatic restorative treatment for primary tooth caries
ACTRN12611000473965Phase 4Recruiting
- Sponsor
- University of Adelaide
- Start
- Jul 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of silver diamine fluoride in carious lesion (2 arms), sponsored by University of Adelaide. Primary endpoint: Failure of treatment. Started Jul 2012; status: recruiting.
02
Drugs
silver diamine fluoride
03
Conditions
carious lesion
Beyond the preview
Go deeper on ACTRN12611000473965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000473965.